Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination

Abstract Background Eliminating hepatitis C virus (HCV) infections is a goal set by the World Health Organization. This has become possible with the introduction of highly effective and safe direct-acting antivirals (DAA) but limitations remain due to undiagnosed HCV infections and loss of patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Medicine
Subjects:
HCV
Lost to follow-up
Treatment
Direct-acting antivirals
Online Access:https://doi.org/10.1186/s12916-024-03699-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12916-024-03699-z

Similar Items